The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.

1. A single administration of the ganglion blocker, chlorisondamine (10 mg kg-1, s.c.) is known to produce a quasi-irreversible blockade of the central actions of nicotine in the rat. The mechanism of this persistent action is not known. It is also unclear whether chlorisondamine can block neuronal...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Clarke, P. B., Chaudieu, I., el-Bizri, H., Boksa, P., Quik, M., Esplin, B. A., Capek, R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 1994
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1909961/
https://ncbi.nlm.nih.gov/pubmed/7911713
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky